AdaptHealth (AHCO) | Financial Analysis & Statements
Financial Overview
Latest Annual: 2024Income Metrics
Revenue
3.3B
Gross Profit
681.1M
20.89%
Operating Income
276.8M
8.49%
Net Income
94.8M
2.91%
EPS (Diluted)
$0.61
Balance Sheet Metrics
Total Assets
4.5B
Total Liabilities
2.9B
Shareholders Equity
1.6B
Debt to Equity
1.84
Cash Flow Metrics
Operating Cash Flow
503.6M
Free Cash Flow
235.8M
Revenue & Profitability Trend
AdaptHealth Income Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 3.3B | 3.2B | 3.0B | 2.5B | 1.1B |
| Cost of Goods Sold | 2.6B | 2.7B | 2.6B | 2.0B | 898.6M |
| Gross Profit | 681.1M | 479.6M | 417.4M | 445.6M | 157.8M |
| Operating Expenses | 359.2M | 190.1M | 162.1M | 156.9M | 75.1M |
| Operating Income | 276.8M | 232.4M | 190.4M | 225.6M | 71.3M |
| Pre-tax Income | 136.0M | -723.8M | 97.9M | 191.0M | -206.0M |
| Income Tax | 41.2M | -49.0M | 24.8M | 32.8M | -12.0M |
| Net Income | 94.8M | -674.8M | 73.1M | 158.2M | -194.1M |
| EPS (Diluted) | $0.61 | -$5.31 | $0.33 | $0.67 | -$1.23 |
Income Statement Trend
AdaptHealth Balance Sheet From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | 755.8M | 649.0M | 585.3M | 670.1M | 363.3M |
| Non-Current Assets | 3.7B | 3.9B | 4.6B | 4.6B | 1.5B |
| Total Assets | 4.5B | 4.5B | 5.2B | 5.3B | 1.8B |
| Liabilities | |||||
| Current Liabilities | 567.0M | 537.0M | 456.2M | 499.8M | 422.1M |
| Non-Current Liabilities | 2.3B | 2.5B | 2.6B | 2.7B | 1.1B |
| Total Liabilities | 2.9B | 3.0B | 3.1B | 3.2B | 1.5B |
| Equity | |||||
| Total Shareholders Equity | 1.6B | 1.5B | 2.2B | 2.1B | 280.8M |
Balance Sheet Composition
AdaptHealth Cash Flow Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 94.8M | -674.8M | 73.1M | 158.2M | -194.1M |
| Operating Cash Flow | 503.6M | -293.5M | 375.9M | 284.9M | 73.9M |
| Investing Activities | |||||
| Capital Expenditures | -306.1M | -337.5M | -391.4M | -203.3M | -39.8M |
| Investing Cash Flow | -310.3M | -357.3M | -411.2M | -1.8B | -815.7M |
| Financing Activities | |||||
| Dividends Paid | - | - | - | 0 | 0 |
| Financing Cash Flow | -200.7M | -95.1M | -70.2M | 1.6B | 648.5M |
| Free Cash Flow | 235.8M | 143.2M | -17.6M | 72.4M | 155.9M |
Cash Flow Trend
AdaptHealth Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
14.47
Forward P/E
9.87
Price to Book
0.71
Price to Sales
0.35
PEG Ratio
9.87
Profitability Ratios
Profit Margin
2.63%
Operating Margin
3.63%
Return on Equity
5.90%
Return on Assets
3.82%
Financial Health
Current Ratio
1.29
Debt to Equity
133.64
Beta
1.64
Per Share Data
EPS (TTM)
$0.58
Book Value per Share
$11.88
Revenue per Share
$24.19
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| ahco | 1.1B | 14.47 | 0.71 | 5.90% | 2.63% | 133.64 |
| Abbott Laboratories | 231.9B | 17.31 | 4.75 | 30.65% | 31.89% | 27.09 |
| Boston Scientific | 149.9B | 73.94 | 6.75 | 9.50% | 11.58% | 52.16 |
| UFP Technologies | 1.9B | 29.89 | 5.20 | 19.36% | 11.59% | 55.05 |
| Alphatec Holdings | 1.6B | -9.63 | -18.58 | 1,144.21% | -25.77% | -6.76 |
| Novocure | 1.9B | -10.90 | 5.12 | -45.52% | -26.41% | 192.49 |
Financial data is updated regularly. All figures are in the company's reporting currency.